Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma

Lu Chen, Yuchao He, Hong Su, Xiangdong Tian, Haotian Liao, Dongming Liu, Meng Zhao, Huichuan Sun, Lisha Qi, Manqing Cao, Zhiyong Liu, Lin Guo, Guangtao Li, Chenhao Zhou, Yi Luo, Liwei Chen, Qiang Wu, Yunlong Cui, Huikai Li, Xiaolin Zhu, Feng Fang, Wei Zhang, Shaojun Zhang, Tianqiang Song, Hua Guo

Open source

DOI: 10.1159/000550945
Published: 2026-02-26
Container: Liver Cancer
Publisher: S. Karger AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/000550945,
  title = {Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma},
  author = {Lu Chen and Yuchao He and Hong Su and Xiangdong Tian and Haotian Liao and Dongming Liu and Meng Zhao and Huichuan Sun and Lisha Qi and Manqing Cao and Zhiyong Liu and Lin Guo and Guangtao Li and Chenhao Zhou and Yi Luo and Liwei Chen and Qiang Wu and Yunlong Cui and Huikai Li and Xiaolin Zhu and Feng Fang and Wei Zhang and Shaojun Zhang and Tianqiang Song and Hua Guo},
  year = {2026},
  journal = {Liver Cancer},
  doi = {10.1159/000550945},
  url = {https://doi.org/10.1159/000550945}
}

RIS

TY  - JOUR
TI  - Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma
AU  - Lu Chen
AU  - Yuchao He
AU  - Hong Su
AU  - Xiangdong Tian
AU  - Haotian Liao
AU  - Dongming Liu
AU  - Meng Zhao
AU  - Huichuan Sun
AU  - Lisha Qi
AU  - Manqing Cao
AU  - Zhiyong Liu
AU  - Lin Guo
AU  - Guangtao Li
AU  - Chenhao Zhou
AU  - Yi Luo
AU  - Liwei Chen
AU  - Qiang Wu
AU  - Yunlong Cui
AU  - Huikai Li
AU  - Xiaolin Zhu
AU  - Feng Fang
AU  - Wei Zhang
AU  - Shaojun Zhang
AU  - Tianqiang Song
AU  - Hua Guo
PY  - 2026
JO  - Liver Cancer
DO  - 10.1159/000550945
UR  - https://doi.org/10.1159/000550945
ER  -

APA

Chen, L., He, Y., Su, H., Tian, X., Liao, H., Liu, D., Zhao, M., Sun, H., Qi, L., Cao, M., Liu, Z., Guo, L., Li, G., Zhou, C., Luo, Y., Chen, L., Wu, Q., Cui, Y., Li, H., Zhu, X., Fang, F., Zhang, W., Zhang, S., Song, T., & Guo, H. (2026). Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma. Liver Cancer. https://doi.org/10.1159/000550945

Source records

crossref · retrieved 2026-09-25T08:58:48.265Z